Presence of human papillomavirus (HPV) in variable proportions in tonsillar squamous cell carcinoma tissues has been demonstrated by several worldwide studies. Some reports emphasized the significance of HPV in predicting a better prognosis, as well as ethnic differences between Chinese and Caucasians. In order to understand the biological role of HPV and find out clinically accessible methods to determine its prognostic significance in primary tonsillar squamous cell carcinoma, we collected 92 patients with primary tonsillar squamous cell carcinoma diagnosed or treated in National Taiwan University Hospital, for whom archival tumor tissue were available. Immunohistochemical stains of p16
In the United States, the annual incidence of head and neck cancer is approximately 30 900 cases; 1 the worldwide annual incidence of head and neck cancer also makes it the fifth most common cancer in the world. 2 In Taiwan, it ranks as the fifth most prevalent cancer in both sexes, and accounts for the fourth most common cancer in males. 3 These tumors have diverse clinical features and distinctive natural histories, and their treatment involves surgery, radiotherapy or chemotherapy alone, or in different sequential combinations. Prognosis has not really improved during the past two decades, although there have been improvements in our understanding of the spreading patterns of invasive tumors, leading to the increased use of combined modality treatment. Clinical staging currently guides treatment but still remains an uncertain predictor of outcome.
Although oral habits like betel nut chewing, cigarette smoking, and alcohol drinking are thought to be major risk factors responsible for the development of oral squamous cell carcinomas in Taiwan, there is a small proportion of patients who do not use betel nut, tobacco or alcohol, yet still develop oral cancer. 4, 5 Several other reports have indicated that patients without oral habits or who are young adults may also develop oral squamous cell carcinoma. [6] [7] [8] Such evidence implies that carcinogenesis by environmental chemical carcinogens is not the only cause of oral squamous cell carcinoma. Presence of human papillomavirus (HPV), especially those genotypes with known high oncogenic potential in the uterine cervix (such as HPV16 and 18), in variable proportions in the oral squamous cell carcinoma tissues has been demonstrated by several worldwide studies. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Recent studies suggest that HPV, especially type 16, may be responsible for a small subgroup of oral squamous cell carcinoma and up to 50% of oropharyngeal squamous cell carcinomas, especially the tonsillar squamous cell carcinoma, [26] [27] [28] [29] [30] [31] [32] [33] despite an ethnic difference between Chinese and Caucasians, as noted in one report. 34 Some reports emphasized the influences of HPV in predicting a better disease prognosis in oropharyngeal and tonsillar cancers. 28, 29 Furthermore, a strong association between the presence of HPV and expression of key cell cycle proteins has been recently reported in a series of tonsillar squamous cell carcinoma. 26, 27 These data seem to strongly suggest that HPV-positive tonsillar squamous cell carcinoma represents a distinct molecular, clinical and pathologic entity. In the present study, we will focus on this distinct subgroup of head and neck cancers.
According to earlier investigations, [35] [36] [37] [38] high-risk HPVs and two HPV-related oncoproteins E6 and E7 can immortalize and transform oral keratinocytes in vitro. These cumulated evidences suggest that HPVs may play a crucial role in the carcinogenesis of head and neck cancer. When the host epithelial cell is infected with the HPV, the HPV genome integrates into the host cell's DNA. It will typically disrupt the HPV E1/E2 open reading frame, resulting in the loss of function of E2, a physiological regulatory protein for the HPV E6 and E7 oncogenes. 39, 40 The E2F-pRb complex dissociates in the presence of the HPV oncoprotein E7; this, in turn, activates E2F, thereby initiating the transcription of genes required for DNA replication and inappropriately forcing the cell past the G1/S restriction point into the S phase. [41] [42] [43] Due to positive feedback, the functional inactivation of pRb by HPV E7 results in the reciprocal overexpression of p16 INK4A . 40, [44] [45] [46] [47] Therefore, p16   INK4A has been considered a complimentary surrogate biomarker for HPV-related uterine cervical and vulvar neoplasia. [48] [49] [50] The same phenomenon was also noted in HPV-related tonsillar squamous cell carcinoma. 26 In accordance with the mechanism described above, previous reports demonstrated a unique region of the E2 open reading frame that is most often deleted during HPV16 integration. Using real-time polymerase chain reaction (PCR), if E2 open reading frame is targeted by one set of PCR primers and a probe, and another set targets the E6 open reading frame, both targets should theoretically be equivalent in episomal form, while in integrated form, the copy numbers of E2 would be less than those of E6. 51 We used three methods, including nested PCRbased genechips, immunohistochemical staining of p16 INK4A , and high-risk HPV in situ hybridization, to detect HPVs and determine their genotypes in 92 primary tonsillar squamous cell carcinoma cases. We then performed real-time PCR to detect DNA products of E2 and E6 open reading frame, in order to calculate the E2/E6 ratio in HPV16-positive cases.
Comparing the clinical and pathologic data of the patients (including staging, survival, oral habits, and histological type, etc.), we hoped to further understand the biological effects of HPV in these tonsillar squamous cell carcinoma cases. 
Materials and methods

Patients
Immunohistochemical and In Situ Hybridization
For immunohistochemical staining, a 5-mm thick section of the tumor tissue was deparaffinized, rehydrated, and then underwent antigen retrieval (DAKO target retrieval solution, high pH, S3307, autoclaved, 10 min). After cooling for 20 min at room temperature, decant retrieval solution was washed 2-3 times in room temperature using PBS solution. The primary antibody p16 INK4A (neomarker; JC-8, 1:50 dilution) was added and the specimen was incubated at 41C overnight. Staining was performed using the Ventana autostainer (DAB detection kit; iVIEW, Ventana Medical Systems, SA, USA). The cases with more than 50% of tumor cells showing strong nuclear staining with/without cytoplasmic staining were considered positive 53 ( Figure 1a ). The in situ hybridization of high-risk HPV was performed using Ventana autostainer (INFORM HPV II Family 16 Probe; in situ hybridization iVIEWt Blue Plus Detection kit; Ventana Medical Systems). According to the manual provided by the manufacturer, each dispenser of the probe we used contains a cocktail of 10 ml of approximately 2 mg/ml of DNP-labeled genomic probes in a formamide-based diluent. This probe cocktail has an affinity to HPV genotypes 16, 18, 31, 33, 35, 45, 51, 52, 56, 58, and 66 . Using this method of in situ hybridization, cases with more than 10% of tumor cells containing the integrated form (nuclear dots) of HPV were considered positive ( Figure 1b ).
DNA Extraction, Nested PCR and Genechips
Four 8-mm tissue sections were cut and deparaffinized, and DNA was extracted using a commercial kit (QIAamp DNA Mini Kit). In order to control the quality and quantity of the isolated DNA, a 300-bp sequence of the b-actin gene was amplified by PCR as internal control to monitor the genomic DNA extraction procedure. Each PCR amplification reaction was carried out in a total volume of 50 ml containing a PCR master mixture (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 800 mM each of dATP, dCTP, dGTP, 600 M dUTP, 10 pmol of each primer set, 1.25 IU/l AmpliTaq Gold DNA polymerase; Applied Biosystems, San Francisco, California, USA). Each PCR was carried out in the Geneamp PCR System 9700 (Applied Biosystems), with the first denaturation step at 941C for 3 min and final extension step at 721C for 5 min. General consensus primers MY09/ GP6 þ were used for the first PCR round to amplify the corresponding part of the HPV L1 gene in accordance with methods reported by others, 54 with some modifications. [55] [56] [57] A nested PCR was then carried out with the primers GP5 þ /GP6 þ according to previously published protocols. 58 A 15-ml volume of the resultant amplified product was then hybridized with an HPV genechip (Easychip HPV Genotyping Array; King Car, Taipei, Taiwan), which offers a revert-blot hybridization to detect 39 subtypes of HPV DNA in a single reaction, as reported by Huang and co-workers.
5,59
Real-Time PCR Real-time PCR was performed in all HPV16-positive [HPV16( þ )] cases with the ABI Prism 7900 Sequence Detection System and the TaqMan Universal PCR Master Mix (Applied Biosystems). Primer and probes used were designed in a previous study 51 and synthesized by Purigo and Prisma. The probes were synthesized with the fluorescent reporter dye FAM (6-carboxy-fluorescein) attached to the 5 0 end and a non-fluorescent quencher with minor groove binder ( Table 1 ). The amplification program included a preincubation step at 951C for 10 min to activate the DNA polymerase, and a two-step cycle of denaturation at 951C for 15 s, and annealing and extension at 601C for 60 s for a total of 40 cycles. The sizes of the E2 and E6 amplimers were 76 and 81 bp, respectively. The final primer and probe concentrations, in a total volume of 25 ml, were 0.3 and 0.1 M, respectively. A 40-ng weight of genomic DNA from the specimens was added to each reaction mixture. negative control. All experiments were performed in triplicate and the mean of them was calculated. In order to demonstrate the status of infection (episomal, mixed, and integrated), E2/E6 ratio was calculated. Integration was defined as absence of the E2 signal or a E2/E6 ratio less than 0.003. 60 A ratio between 0.004 and 0.999 indicates mixed episomal and integrated form, and a ratio not smaller than 1 means the episomal form is predominant. 60 
Statistical Analysis
Data on clinical and pathological characteristics were compared by the Mann-Whitney test for continuous variables and the w 2 -test for categorical variables. For analyses of survival rate, death from any cause was considered an event and data on patients who were alive at the last follow-up contact were censored. The Kaplan-Meier method was used to estimate the probabilities of survival. The multivariate analysis was used for finding out independent variables. The proportional hazards model was used with stepwise backward selection to evaluate independent prognostic factors for survival. These analyses were performed using SPSS for Windows version 11.0 software.
Results
Patient Characteristics and Treatment
The characteristics, treatment, and overall survival of 92 patients are summarized in Table 2 . Data on specific treatment modality were lacking in 16 cases. The treatment modalities included surgery alone (n ¼ 6), surgery followed by radiotherapy (n ¼ 13), surgery followed by concurrent chemoradiation (n ¼ 25), radiotherapy alone (n ¼ 7), concurrent chemoradiation (n ¼ 20), chemotherapy followed by radiotherapy (n ¼ 4), and chemotherapy followed by surgery (n ¼ 1). We divided the treatment modalities into two groups (definitive surgery and definitive radiotherapy). The overall survival rates between these groups did not differ significantly (data not shown, P ¼ 0.94).
Data Associated with HPV Infection Status
Sixty-nine (75%) cases were positive for HPV nested PCR, and HPV DNA types 16, 18, 33, 35, 58, 66 , and 69 can be detected in 58, 2, 2, 1, 3, 1, and 2 cases, respectively. The cases with HPV genotypes 35, 58, and 69 were positive for both p16
INK4A immunostainings and high-risk HPV in situ hybridization, INK4A immunostaining, but all cases had negative results for high-risk HPV in situ hybridization.
Comparing Clinical Data with Differentiated Methods
HPV-related tonsillar squamous cell carcinoma apparently tends to develop in patients who do not use alcohol, betel nut, or cigarettes, regardless of the method chosen to represent HPV infection (Table  2) . A non-keratinizing histological type and a more favorable 5-year survival rate seem to characterize HPV-related tonsillar squamous cell carcinoma with positive p16
INK4A immunostaining or high-risk HPV in situ hybridization (Table 2) . Statistically, female patients seemed more likely to develop HPV-related tonsillar squamous cell carcinoma when using nested PCR for detection (Table 2) .
Survival Analyses
Univariate analysis demonstrated that consumption of alcohol, betel nuts, and cigarettes was significantly associated with shorter survival and that patients with overexpression of p16 INK4A or in situ hybridization HPV-positive disease were significantly associated with longer survival (Table 3 ; Figure 2a- 
c). HPV-PCR, p16
INK4A and in situ hybridization were separately analyzed with all the clinical and pathological variables in multivariate analyses, which demonstrated that both p16 INK4A and in situ hybridization were independent prognostic factors, but HPV-PCR was not. In HPV16( þ ) cases, positive p16
INK4A and in situ hybridization were also significantly associated with longer survival (Figure 3a and b) . Using real-time PCR, HPV16( þ ) patients with integrated and mixed forms of HPV DNA also shared significantly longer survival times than those with episomal forms of HPV DNA or lower viral DNA copies (o10 2 ) (Figure 3c ). 
Discussion
HPV infection, like alcohol and tobacco, is now recognized to play a role in the pathogenesis of head and neck squamous cell carcinoma, especially in the tonsillar area, which appears uniquely susceptible to transformation by the virus. 5, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [31] [32] [33] HPVs are known not to work via a hit-and-run mechanism; therefore, demonstration of HPV genomic DNA in the tumor is essential for it to play a role in carcinogenesis. 61 In this study, we used three methods to detect or represent HPV directly or indirectly in the tonsillar squamous cell carcinoma tissue, and the positive rate ranged from 43 to 75%. In comparison with previous reports, [26] [27] [28] [29] [30] our findings are consistent with these reports and it seems that there are no differences between Caucasian and non-Caucasian patients, which is different from the results of Li et al. 34 Comparing the HPV-positive rate detected by similar PCR methods, it is significantly different in oral and tonsillar malignancies (41.7 vs 75.0%, Po0.001).
5 This difference was also noted in previous articles 27, [29] [30] [31] and in a more recent review article. 62 This finding may be associated with anatomic site specificity. Like the cervix and anus, 63 where squamous cell carcinomas are also highly associated with HPV, transitional zones between different epithelial linings exist in the tonsillar area. Perhaps under these circumstances, the basal cell and the basal extracellular matrix (which are thought to be HPV receptors 64 ) are more likely to be exposed and infected by environmental HPV. According to our data and previous articles, we therefore believe that the anatomic site rather than ethnicity may influence the biological pathways of HPV-induced mucosal cancer.
In our study, irrespective of the method we used, HPV-positive tonsillar squamous cell carcinoma was more likely to occur in patients without alcohol, cigarette, and betel nut usage than HPV-negative tonsillar squamous cell carcinoma. Similar results have been proven by other reports. 30, 65, 66 This may imply that in tonsillar squamous cell carcinoma patients who live relatively 'healthier' lifestyles, carcinogenesis may be associated with HPV. Although some studies have found associations between advanced TNM staging and HPV positivity, these findings have been somewhat inconsistent. HPV-positive tumors tend to have non-keratinizing histology (Figure 4a and b) , 30, 65, 67, 68 a point also demonstrated in our study. Using the methods of high-risk HPV in situ hybridization and immunostaining of p16 INK4A , our data, like previous reports, [28] [29] [30] 69 disclosed a better 5-year survival in HPV-positive tonsillar squamous cell carcinoma than HPV-negative tumors. Multivariate analysis also showed positive high-risk HPV detection (in situ hybridization), or expression of related proteins, (immunostaining of p16 INK4A ) to be one of the most important independent prognostic factors. The reason for the favorable prognosis in patients with HPV-positive tumors is still unclear. Some studies proved E6-related degradation of p53 in HPVpositive cancers may be functionally inequivalent to HPV-negative p53 mutations, 70, 71 and therefore, HPV-positive cancers may have an intact apoptotic response to radiation and chemotherapy. 72 On the other hand, in vitro cell line studies have revealed that HPV oncoproteins E6 and E7 mediate suppression of NF-kB transcriptional activity; this may contribute to HPV escape from the immune system in cases of HPV-related carcinogenesis and poor tumor cell recovery after radiation and chemotherapy. 73 A prophylactic vaccine composed of the HPV16 viral capsid protein has recently been shown to prevent persistent HPV16 infection and development of cervical dysplasia in phase three randomized controlled trials, 74, 75 but the trials have not included the evaluation of head and neck HPV infection. Data on the influence of head and neck HPV infection under immunization are limited to canine and hamster models, 76, 77 which did show protective effects and a reduction in the development of HPV-positive lesions. If vaccines can give HPV-related tonsillar squamous cell carcinoma the same protective effect, we then have to tackle the HPV-negative neoplasms with unfavorable prog
